Wild-Type and Genetically Improved Strains of Dairy Origin Probiotic as Potential Treatments for Intestinal Mucositis
Journal: Journal of Pharmacy and Pharmacology (Vol.7, No. 4)Publication Date: 2019-04-04
Authors : Flávia Figueira Aburjaile; Gwénaël Jan; Yves Le Loir; Vasco Azevedo; Rodrigo Dias de Oliveira Carvalho;
Page : 177-186
Keywords : ;
Abstract
The use of probiotic bacteria derived from fermented foods has been explored by the scientific community as alternative strategies for the treatment of several diseases, mainly regarding intestinal dysfunction. One of the most relevant inflammatory diseases affecting the alimentary tract, for which no current intervention is entirely successful, is mucositis. In this review article, we summarize the most recent proof-of-concept studies dealing with the therapeutic use of dairy origin probiotics, for the treatment of gastrointestinal mucositis. Furthermore, we discuss several approaches for the improvement of the classical therapeutic rationale, such as supplementation with prebiotics and genetic engineering along with the respective translational issues, which may be crucial for the successful transposition of these therapeutic strategies for clinical use.
Other Latest Articles
- Pharmacokinetic, Physicochemical and Medicinal Properties of N-glycoside Anti-cancer Agent More Potent than 2-Deoxy-D-Glucose in Lung Cancer Cells
- Tibolone Reverses NAFLD in Ovariectomised Rats by Reducing Adiposity and Insulin Resistance
- Agnuside Reduces Visceral Adipocyte Size, Improves Insulin Sensitivity and Reverses Hepatic Steatosis in Ovariectomized Rats
- Pain Exposure Physical Therapy (PEPT) in Complex Regional Pain Syndrome Type 1: A Systematic Review
- Ciprofloxacin Residue in Marketed Pork of North-East India
Last modified: 2022-06-24 11:16:03